Alternatives to SubtleMR

SubtlePET enhances image quality through denoising techniques, allowing scans to be completed in just a quarter of the usual time while still delivering diagnostic images that match the quality of the original ground truth images. This technology significantly boosts the effectiveness of accelerated scanning protocols. By shortening scan durations, facilities can efficiently accommodate patients, which is particularly advantageous for young children under sedation or those who struggle to remain still. Reduced scanning time not only alleviates patient discomfort and anxiety but also minimizes potential pain associated with prolonged procedures. Additionally, SubtlePET optimizes the throughput of existing PET machines by enabling hospitals and imaging centers to process more patients daily, thereby decreasing wait times and enhancing PET capacity, while simultaneously creating additional opportunities for other imaging applications, such as CT and cardiac PET. This improvement in efficiency underscores the importance of innovative technologies in modern medical imaging practices.

Mend is an enterprise-grade patient engagement and integrated telehealth solution designed to help healthcare organizations profitably scale their practice and care for more patients. Mend makes it easy for healthcare providers to securely and efficiently communicate with their patients and is 100% HIPAA compliant. Mend provides integrated in-office and virtual care experiences for over 100 specialties with more than 5 million patients.

Our innovative AI solution empowers healthcare practitioners to conduct high-quality ultrasound examinations anytime and anywhere, irrespective of their experience level with ultrasound technology. While ultrasound serves as a reliable and effective diagnostic instrument, mastering its use can be challenging, requiring extensive specialized training and often resulting in variable image quality. The examination process demands precise hand-eye coordination and can be visually unintuitive, complicating the learning curve. Moreover, conventional ultrasound software fails to provide guidance on how to maneuver the ultrasound transducer effectively or offer immediate feedback regarding the clarity of the images obtained. This can lead to subpar imaging, which in turn results in overlooked diagnoses, unnecessary repeat exams, and inconsistent interpretations of the results. Consequently, the full potential and advantages of ultrasound technology have not been completely harnessed. With the advent of our AI-driven technology, any healthcare provider can now effortlessly capture high-quality diagnostic ultrasound images, as the AI assists them throughout each phase of the scanning procedure, ensuring accuracy and efficiency. This advancement not only enhances the diagnostic capabilities of healthcare providers but also promotes better patient outcomes through timely and accurate assessments.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

We streamline clinical processes, allowing you to prioritize what truly matters: caring for your patients. Integrated within the electronic health record (EHR), Regard thoroughly analyzes the entire patient record, facilitating improved diagnosis and treatment. The effectiveness of Regard has been shown to significantly enhance hospital financial performance, promote patient safety, and increase physician satisfaction. By minimizing coding queries, reducing insurance denials, and cutting down the time spent on chart review, we aim to transform healthcare delivery. We invite you to be part of our vision to provide exceptional healthcare for all. Specifically designed for healthcare providers, Regard optimizes workflow, resulting in a more efficient and satisfying experience with the electronic medical record (EMR). By functioning as an AI co-pilot that integrates seamlessly into the EMR, Regard acts as a virtual medical resident, organizing patient information, proposing new diagnoses, and automating the creation of clinical notes. With Regard, you will have more opportunities to engage in the aspects of medicine you are passionate about, while our technology handles the intricacies of data management. Ultimately, Regard's AI co-pilot is an invaluable tool that enhances both patient care and the physician experience.

GE HealthCare's cutting-edge AI technologies enhance scanning instructions, boost workflow efficiency, and provide improved support for clinical decisions within our ultrasound range. This advancement aims to elevate quality and ensure that even novice ultrasound practitioners feel assured while performing scans. Caption Guidance aids clinicians across all experience levels in mastering cardiac imaging through AI-driven image enhancement. With step-by-step on-screen assistance, newcomers can approach scanning tasks with greater assurance. Additionally, a quality meter evaluates image clarity to ensure diagnostic-grade results. The AutoCapture feature conveniently saves images automatically, eliminating the need to manually press record. By empowering a wider segment of your team with the capabilities of cardiac ultrasound, we strive to enhance patient care accessibility. Our GE HealthCare ultrasound systems integrate AI features that can positively impact your everyday operations, spanning from cardiology to point-of-care ultrasound (POCUS) and beyond. Seize control of cardiac image acquisition with the innovative guidance provided by our caption assistance. Ultimately, this transformative technology makes it easier for healthcare professionals to deliver accurate and timely diagnostics.

The Bookend Healthcare AI Agent platform enhances administrative efficiency across all stages, from patient care to payment processing. By simplifying intricate prior authorization procedures, it relieves healthcare providers from labor-intensive tasks and minimizes expensive denials. Through automation, we enable an increase in operational efficiency, expedite revenue cycles, and significantly enhance patient outcomes. Our sophisticated agents evaluate patient information, interpret insurance policies, and compile essential details for precise and prompt submissions, which leads to elevated approval rates and quicker reimbursements. Additionally, our AI-driven platform transforms the healthcare landscape by streamlining the creation and implementation of tailored care plans. We assist healthcare providers in proactively recognizing evidence-based interventions that optimize patient outcomes while simultaneously lowering costs. Moreover, this platform equips clinicians with the tools to make informed decisions based on data, thereby raising the quality of care and boosting patient satisfaction levels, ultimately fostering a more effective healthcare system.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Arterys is an innovative medical imaging AI platform that seamlessly integrates advanced AI clinical applications into your existing PACS or EHR workflows, making it an intuitive extension of your current practices. Our goal is to bring AI into the forefront by enhancing physician experiences, improving diagnostic accuracy and treatment efficacy, optimizing financial outcomes, and providing significant benefits for both patients and healthcare providers. Accessible from any validated device through the cloud, it offers rapid performance and easy deployment without the exchange of PHI, ensuring complete security. Fully connected to PACS, RIS, EMR, and dictation software, Arterys enhances your workflow without disruption. Its rapid deployment capabilities require minimal on-premise infrastructure, and it is commercially available in more than 100 countries. The platform's elastic cloud GPU architecture significantly boosts the performance of various tasks, such as rendering complex 3D files, handling large multi-dimensional datasets, and executing multiple AI applications simultaneously in real time. Additionally, features like pre-fetching and image caching contribute to quicker loading times and more efficient analysis, making it an indispensable tool in modern healthcare. This comprehensive approach positions Arterys as a leader in transforming medical imaging through artificial intelligence.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

HeartFlow offers a groundbreaking, non-invasive cardiac test that delivers detailed visualizations of individual coronary arteries, allowing doctors to develop more tailored treatment strategies for their patients. The process begins when a patient has a standard coronary computed tomography scan performed at a medical facility. Following this scan, the CT images are securely sent to our cloud-based system. Utilizing cutting-edge algorithms powered by artificial intelligence, we create a customized digital representation of the patient's coronary arteries. Our skilled analysts then review this model, making necessary adjustments to ensure accuracy. After finalizing the patient-specific model, the HeartFlow pathway employs physiological principles and computational fluid dynamics to analyze blood flow and compute FFRCT values throughout the model. We adhere to strict and well-established protocols throughout this entire process, ensuring uniform processing for every individual patient, which ultimately enhances the quality of care provided. This innovative approach not only improves diagnostic precision but also empowers healthcare providers to make informed decisions for optimal patient outcomes.

Developed by healthcare professionals for their peers, this technology aims to significantly enhance the quality of life for patients. Our AI-driven platform emphasizes speed, scalability, and security while offering the flexibility and customization that each hospital requires. It serves as a dependable long-term resolution. With RapidAI's stroke portfolio, you can expedite triage and transfer decisions with greater precision. Additionally, it facilitates the swift identification, monitoring, and proactive management of aneurysms. RapidAI's comprehensive suite of products for pulmonary embolism care enables quick detection of suspected PE cases. The AI-enhanced clinical decision support (CDS) software accelerates the decision-making process for physicians; however, it is crucial to recognize that not all AI solutions are equal. Only those CDS tools that possess clinical expertise can accurately identify, locate, characterize, and quantify suspected conditions. This advanced level of precision in AI-powered CDS modules contributes to improved triage and transfer decisions, ultimately leading to enhanced diagnostic accuracy and more efficient vascular care. By integrating these cutting-edge tools, healthcare providers can significantly elevate patient outcomes and operational efficiency.

Use AI agents to automate the review of patient charts, saving time, improving productivity, and improving the mental health of physicians. This will improve the quality of care provided to patients. Sporo allows the clinician to focus on what is important, the patient. Manual Chart Review (MCR), which consumes a lot of time, leads to physician burnout and poor patient outcomes. We combine the latest advances to create state-ofthe-art AI agents which analyze pages of patient chart and provide synopses that can be reviewed in only 10 seconds. We've created the perfect solution for modern healthcare with the best technology and expert advisors. Sporo can help you save time and effort by focusing on key elements in a patient's history.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Innovative AI solutions that smoothly integrate with your PACS and radiology processes empower radiologists to streamline their workflows and enhance patient care. As the demand for medical imaging continues to rise, radiologists are often overwhelmed by the sheer volume of data, which can lead to increased reporting errors, elevated workloads, and disorganized processes. By automating repetitive tasks and standard measurements, AI technology assists radiologists in producing high-quality, evidence-based reports. This enhancement not only aids referring doctors and physicians in making well-informed decisions but also fosters a more intuitive workflow, ultimately benefiting patient care. Furthermore, these systems excel at identifying, characterizing, and classifying critical elements with pinpoint accuracy while maintaining the highest image quality and ensuring rapid loading times. Additionally, the inclusion of intelligent suggestions during report template searches, along with the ability to use pre-filled or customizable report templates, greatly improves standardized clinical communication and efficiency in the reporting process. By adopting such advanced tools, radiologists can focus more on patient interactions and less on administrative burdens.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

See-Mode Technologies is a MedTech firm focused on utilizing AI to enhance ultrasound reporting, thereby boosting both diagnostic accuracy and operational efficiency. Their innovative platform swiftly analyzes ultrasound images of the thyroid and breast, resulting in rapid and precise radiology reports. By identifying, measuring, and characterizing nodules, See-Mode produces a comprehensive TI-RADS sonographer worksheet along with initial impressions for radiologists. In the realm of breast imaging, the software not only detects lesions but also automates the BI-RADS reporting process, offering detailed insights into lesion characteristics and levels of suspicion. This advanced technology minimizes inter-operator variability and reduces the likelihood of reporting errors, ultimately strengthening diagnostic confidence and ensuring consistency. By streamlining the reporting process, See-Mode facilitates more informed clinical decisions, which can lead to better patient outcomes.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Envision a transformative approach to care management that lowers healthcare expenses, reduces both admissions and readmissions, enhances star ratings and HEDIS metrics, and elevates health quality and outcomes through a mission-focused data platform driven by artificial intelligence. As the healthcare sector increasingly embraces value-based care, Health EM.AI emerges as a pioneer, redefining care management and enhancing care delivery through innovative data utilization and AI technology. By streamlining patient information from various care settings and leveraging AI/ML-driven predictive analytics, we equip healthcare organizations with actionable insights that significantly enhance care quality. Our approach ensures measurable improvements at the individual patient level, particularly within palliative and chronic care management workflows. The integration of unified patient 360 data across all care settings leads to meaningful advancements in star ratings, risk adjustment, and the effective closing of care gaps. Additionally, our localized healthcare models examine over 1,000 clinical and non-clinical variables based on geographical context, further refining the effectiveness of care. This comprehensive strategy not only fosters better patient outcomes but also encourages a more efficient healthcare ecosystem.

Techcyte develops innovative machine learning applications specifically for cellular and liquid-based environments, designed to enhance the capabilities of laboratories and professionals in the field of digital diagnostics. Our commitment is to provide comprehensive solutions that offer a seamless and effective user experience at every stage, from sample preparation through to workflow execution and image interpretation, ensuring that we consistently deliver reliable outcomes. We recognize that the most significant breakthroughs in technology and healthcare stem from the ingenuity and dedication of talented individuals. Notably, our Cervical Cytology System serves as a groundbreaking screening instrument, enabling cytotechnologists and pathologists to analyze Hologic ThinPrep® or BD SurePath™ slides with greater efficiency by dramatically minimizing the number of cells they need to assess, all while highlighting the most diagnostically critical cells and organisms through our advanced AI-driven algorithm, optimized laboratory workflows, and integration with Laboratory Information Systems (LIS). This innovative approach not only streamlines the diagnostic process but also elevates the overall quality of patient care.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Our healthcare enablement platform significantly reduces the administrative burden on clinicians, leading to enhanced experiences for patients. By streamlining the process of connecting patients to the appropriate care swiftly, we can increase patient volumes effectively. This system minimizes the time clinicians spend on non-clinical tasks, alleviating frustration and burnout by automating various administrative responsibilities. Additionally, we create a cohesive and integrated technological environment that complements your current EMR system. With the power of conversational AI and intelligent adaptive interviews, Fabric brings together virtual and in-person healthcare services seamlessly, covering all aspects from intake to treatment while automating staff workflows. Developed based on clinical guidelines by a dedicated team of healthcare professionals, Fabric’s clinical intelligence engine ensures high standards of care quality, while also providing patients with omnichannel access to services. This approach not only enhances operational efficiency but also fosters better patient outcomes and satisfaction.

Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.

ZAIDYN is a cutting-edge, cloud-based platform crafted by ZS aimed at transforming the life sciences sector. This innovative tool combines sophisticated analytics, machine learning capabilities, and smart workflows to help organizations streamline their processes in research and development, commercialization, and patient interaction. Designed with a modular approach, ZAIDYN offers scalable solutions that can be customized to meet diverse requirements, enabling smooth integration with current IT systems thanks to its open architecture. By delivering cohesive, high-quality data and insights, the platform fosters enhanced collaboration across different functions, which minimizes operational silos and encourages more informed decision-making. Prioritizing security and compliance, ZAIDYN upholds data privacy and meets regulatory standards, establishing itself as a trustworthy option for life sciences companies striving to innovate and elevate health outcomes. Ultimately, its comprehensive features provide organizations with the tools they need to navigate the complexities of the industry effectively.

CARPL.ai serves as a vendor-agnostic artificial intelligence platform designed to empower radiologists in accessing, evaluating, and incorporating a wide range of radiology AI solutions into their everyday clinical workflows. This innovative platform boasts an extensive collection of over 140 AI applications from more than 60 different vendors, thereby aiding in the discovery, exploration, validation, and implementation of various AI tools. By providing a unified technical integration along with a user-friendly interface, CARPL.ai simplifies the process of adopting multiple AI systems effectively. The platform is versatile, accommodating both cloud-based and on-premise deployments to suit diverse clinical settings. Additionally, it features a universal AI viewer that allows for the viewing, editing, and annotating of AI-generated outputs while also providing pre-deployment validation and ongoing post-deployment monitoring to maintain the systems' performance over time. With seamless integration into existing Picture Archiving and Communication Systems (PACS), CARPL.ai enhances patient care, minimizes turnaround times, and boosts diagnostic accuracy, ultimately transforming the radiology landscape for better healthcare outcomes. Furthermore, its commitment to adaptability and ease of use makes it a valuable asset for radiologists looking to leverage AI technology in their practices.

The Medical Imaging Suite from Google Cloud is crafted to revolutionize the way organizations handle imaging diagnostics by ensuring that imaging data is not only accessible but also interoperable and beneficial. This suite provides a secure, compliant, and fully managed service to oversee healthcare data in various formats such as FHIR, HL7v2, and DICOM, alongside unstructured text in natural language. Utilizing a cloud infrastructure simplifies the process of storing and sharing extensive collections of medical images that are prevalent in the healthcare sector, making it both efficient and economical. The Cloud Healthcare API facilitates operations to read DICOM instances, studies, and series in alignment with the DICOMweb standard. Furthermore, the suite enhances research capabilities and improves the overall patient experience in healthcare by providing comprehensive solutions for data storage and analysis, among other functionalities. Additionally, it offers guidance on concepts and best practices for the integration of third-party medical imaging viewers with the Cloud Healthcare API, ensuring a seamless experience for users. This holistic approach not only streamlines workflow but also fosters innovation in the medical imaging landscape.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

MIM Fertility is committed to improving the success rates of in vitro fertilization by leveraging artificial intelligence (AI) and data analytics. Our focus has been on creating AI solutions that empower IVF clinics to help patients realize their dreams of parenthood. We strive to redefine fertility care standards, aiming to transform the journey of infertility and ensure greater access to fertility solutions globally. Among our innovative offerings are AI-driven software platforms such as EMBRYOAID and FOLLISCAN. EMBRYOAID aids embryologists and physicians by quickly assessing the most promising embryos using images and time-lapse technology, which improves the embryo selection process for IVF. Meanwhile, FOLLISCAN serves as an ovarian follicular monitoring tool that effectively counts and measures follicles of varying sizes through 2D or 3D cine-loops of the ovaries, streamlining imaging ultrasonography workflows to boost diagnostic precision. By integrating advanced technology into fertility treatments, we believe we can significantly enhance patient experiences and outcomes.

Clario’s Image Redact AI efficiently removes sensitive patient identifiers from various media formats, including videos, photos, and PDFs. This cutting-edge solution combines AI-powered de-identification with the vigilant oversight of a skilled quality control (QC) team, ensuring compliance with EU GDPR and other privacy laws. By implementing this technology, organizations can mitigate the risk of significant penalties and potential liabilities stemming from data breaches. Each image undergoes a thorough de-identification process, leveraging our unique AI capabilities alongside comprehensive human visual QC review to confirm that all necessary redactions have been executed. Additionally, all images are securely stored across multiple geographical locations in data centers that conform to the latest security standards and practices. Users can effortlessly access and evaluate their protected videos, photos, and PDFs on any device, making it an invaluable resource for clinical trial research projects, while also enhancing overall data security and accessibility.

Introducing artificial intelligence for IVF directly at the point of care, revolutionizing the influence of extensive image and text data on business insights in reproductive medicine. We have gathered a team of the foremost specialists in artificial intelligence, IVF lab quality control/assurance, and digital technology solutions to develop this innovative platform, which boasts the largest open-source image database dedicated to embryology and andrology competency assessment globally. ART Compass emerges as the state-of-the-art IVF Lab Information Management System (LIMS), enhancing IVF lab quality management through artificial intelligence, all accessible via a user-friendly smartphone app. This platform allows for the evaluation of embryology and andrology competency assessments, as well as supports clinical decision-making in these fields. Users can also access annual procedure evaluation documentation, record new training for procedures, and onboard new staff seamlessly. Furthermore, it enables tracking of pregnancy outcomes for each IVF cycle while providing all necessary statistics. In addition, it facilitates management of patient cryostorage inventory and efficiently delivers preimplantation genetic testing results to physicians, ensuring a comprehensive approach to reproductive health. Ultimately, ART Compass is not just a tool; it represents a significant advancement in how IVF labs can operate and improve patient care.

Meet Liine, an AI-powered platform that simplifies the process of acquiring new patients for healthcare practices. Run your healthcare practice like a healthcare business. All phone and online inquires can be captured in one intuitive platform. Respond to interested leads within minutes, not days or hours. Instantly convert website form submissions to inbound calls. All your marketing and patient acquisition metrics automatically captured. Stop wondering why your practice is growing. With the clarity and conviction that comes from data, you can manage front-line operations. To improve patient experience and conversion rates, implement patient-centric phone messaging. To praise top performers, you can use individual performance metrics. Recognize staff members who book more patient appointments. The scheduling of relevant new patient opportunities is 76% easier for practices.

At Enlitic, we believe that the power of artificial intelligence can transform healthcare by enabling effective data management and improving clinical workflows. Our mission at Enlitic is to intelligently manage healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. Through our Enlitic Framework, we aim to reimagine healthcare intelligence, enabling healthcare professionals to make informed decisions and provide personalized care to every patient.

Medgnosis is a cutting-edge application tailored to enhance the interpretation of X-ray images by radiologists. Utilizing sophisticated machine learning techniques, it meticulously analyzes user-selected X-ray images to predict possible abnormalities. This tool serves as an invaluable resource, enriching the diagnostic process with an extra layer of expertise and efficiency. By employing deep learning and neural networks trained on a vast array of data, Medgnosis proficiently detects a diverse range of conditions visible in X-ray scans. Its performance not only rivals but often exceeds traditional diagnostic methods, featuring a system that is continually refined to remain at the leading edge of medical technology. Additionally, Medgnosis produces comprehensive diagnostic reports swiftly, integrating detailed health issue identification, evaluations of severity, and suggested next steps into an easily understandable format. This efficient methodology significantly aids healthcare professionals in making prompt and informed decisions, ultimately enhancing patient care outcomes. Furthermore, the user-friendly interface ensures that even those with limited technical expertise can effectively utilize the application.

No doctor should have to navigate through mountains of chaotic patient information. Our streamlined and user-friendly platform effectively structures even the most intricate cases, ensuring that fast evaluations and proactive treatment are accessible to all. It provides a thorough, concise, and context-aware clinical summary. Navina seamlessly integrates with your electronic health records, as well as claims data and a variety of patient information. This actionable synthesis at the point of care enhances the quality of treatment while also boosting reimbursement rates. It is all too common for essential data to be lost within the depths of the EHR system. By leveraging AI technology, Navina brings that vital information to the forefront and displays it in a clear and intuitive manner. In addition, we utilize data analytics to identify and propose potential diagnoses and offer other clinical insights derived from often overlooked discharge documents, laboratory results, and various other records. Ultimately, our goal is to empower healthcare professionals with the tools they need to provide the best possible care.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

Microsoft's Dragon Copilot represents a sophisticated AI-powered tool aimed at optimizing clinical processes through the automation of documentation, thereby alleviating administrative pressures. By seamlessly integrating with the Microsoft Cloud for Healthcare, it assists healthcare professionals in efficiently generating precise documentation based on interactions between patients and clinicians. This innovative solution accommodates various languages and retains functionality without internet access, enabling the collection of patient information and its transformation into notes tailored to specific medical specialties. Additionally, Dragon Copilot harnesses AI technology to propose enhancements for clinical interactions, automatically completes orders, and enables clinicians to search through notes and retrieve medical data, ultimately enhancing both operational efficiency and the quality of patient care. With its ability to adapt to the needs of healthcare providers, Dragon Copilot is poised to significantly revolutionize the way clinical documentation is handled.